Equities

Fangzhou Inc

Fangzhou Inc

Actions
Health CareHealth Care Providers
  • Price (HKD)7.45
  • Today's Change0.09 / 1.22%
  • Shares traded708.50k
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 05 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Fangzhou Inc is an investment holding company principally engaged in the provision of online chronic disease management services. The Company operates its businesses through three segments. Comprehensive Medical Services segment is mainly engaged in provision of follow-up consultations, E-prescriptions services and pharmaceutical products and home delivery services. Online Retail Pharmacy Services segment is mainly involved in provision of healthcare products and home delivery and prescription verification or e-prescription services. Customized Content and Marketing Solutions segment is mainly involved in provision of services such as academic community services and patient community services, search engine optimization, provision of medical surveys, and distributor data integration services.

  • Revenue in HKD (TTM)2.69bn
  • Net income in HKD-940.93m
  • Incorporated2021
  • Employees515.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Sipai Health Technology Co, Ltd5.06bn-263.89m3.94bn3.25k--2.41--0.7776-0.336-0.3366.662.141.5813.619.781,635,929.00-7.98---13.82--9.18---5.05--1.58--0.0386--14.39--81.34------
JZJ Chain Drugstore Corp10.20bn259.25m4.40bn16.65k16.731.45--0.43121.531.5360.2017.720.92582.2020.72559,572.202.345.754.5011.1735.5435.212.535.040.26552.880.656336.6220.8426.8410.7225.4123.62--
Genky DrugStores Co Ltd9.61bn330.23m4.81bn1.66k14.291.927.730.5003212.46212.466,180.371,582.201.676.4743.31113,208,300.005.764.948.657.8620.4120.673.442.980.410259.820.41958.249.3512.2132.7518.58-0.53160.3968
MedPlus Health Services Ltd5.38bn70.25m7.40bn21.00k105.78--26.001.376.346.34485.51--------2,775,897.00--2.68--3.4822.1121.141.311.38--1.48--0.0023.4219.8731.5740.5931.14--
Fangzhou Inc2.69bn-940.93m9.86bn515.00------3.66-0.702-0.7022.01-1.62------5,229,344.00--------20.52---34.94--0.699--30.75--10.43--48.66------
Welcia Holdings Co Ltd63.19bn1.12bn20.09bn15.29k17.681.578.550.3179106.05106.055,982.481,194.412.116.3117.0880,917,640.003.675.766.6310.2330.2330.811.742.510.651138.940.234323.976.389.33-2.148.712.5910.12
Dashenlin Pharmaceutical Group Co Ltd29.05bn930.86m20.86bn45.47k22.472.77--0.71790.74450.744523.376.031.124.1423.28583,716.303.906.578.1512.6333.8037.513.475.540.5987.150.598145.6715.4522.5912.6317.0226.516.85
Yifeng Pharmacy Chain Co Ltd26.19bn1.67bn34.38bn39.65k20.583.06--1.311.261.2619.778.460.97344.0014.51603,225.006.726.9312.7612.4738.4738.736.906.710.877134.970.523726.5613.5926.7211.5727.6625.9333.54
MatsukiyoCocokara & Co52.83bn2.66bn44.10bn13.37k16.671.6711.500.8347124.58124.582,476.561,241.321.474.7317.8977,335,880.007.436.809.598.8734.7333.455.064.571.31--0.036228.657.4912.1629.1115.9029.3811.10
Data as of Nov 05 2024. Currency figures normalised to Fangzhou Inc's reporting currency: Hong Kong Dollar HKD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.